You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 17, November 4, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Brain Cancer
 •Quality of Care
 •Evidence-Based Medicine
 •Radiation Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of a Single Brain Metastasis

The Role of Radiation Following Surgical Resection

Arlan Pinzer Mintz, MD, MSc, FRCSC; J. Gregory Cairncross, MD, FRCPC

JAMA. 1998;280:1527-1529.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Metastatic brain tumors are the most common intracranial neoplasms.1 Fifteen percent to 30% of patients with cancer develop cerebral metastases during the course of their illness.2-3 Carcinomas of the lung, breast, colon, and kidney and malignant melanoma are the common primary sources. At the time of neurologic diagnosis, 50% of patients will have a single brain metastasis shown on computed tomographic scan,4-5 whereas fewer than 30% will have only 1 lesion shown on magnetic resonance imaging, a more sensitive imaging method.6 The median survival of untreated patients with brain metastases is approximately 1 month,7 although survival time can be doubled by the use of corticosteroids.8 When added to corticosteroid treatment, whole-brain radiation therapy may further improve neurologic function with tolerable morbidity, although survival times remain short, ranging from 3 to 6 months.9-10

Patients with cerebral metastasis die as a . . . [Full Text of this Article]

From the Department of Surgery, Division of Neurosurgery, Faculty of Health Sciences, McMaster University, Hamilton, Ontario (Dr Mintz), and the Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario (Dr Cairncross).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
Roy A. Patchell, Phillip A. Tibbs, William F. Regine, Robert J. Dempsey, Mohammed Mohiuddin, Richard J. Kryscio, William R. Markesbery, Kenneth A. Foon, and Byron Young
JAMA. 1998;280(17):1485-1489.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Resectable Brain Metastases
Vogelbaum and Suh
JCO 2006;24:1289-1294.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.